Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumabDavid R. Gandara, David S. Shames, Wei Zou et al.|Nature Medicine|2018Cited by 1.2k
Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial CancersDavid T. Ting, Daniel A. Haber, Doron Lipson et al.|Science|2011Cited by 557